Company Nanjing Well Pharmaceutical Group Co.,Ltd.

Equities

603351

CNE100003JD4

Oil & Gas Refining and Marketing

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Oil & Gas Refining and Marketing

NANJING WELL PHARMACEUTICAL GROUP CO.,LTD.

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
24.68 ^CNY	+2.41%		+3.87%	-6.41%

25/04	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Nanjing Well Pharmaceutical Group Co Ltd, formerly Nanjing Well Pharmaceutical Co Ltd, is a China-based company principally involved in the research and development, manufacturing and sales of pharmaceutical auxiliary materials and synthetic lubricating base oil products. Its main products include pharmaceutical auxiliary materials, synthetic lubricating base oil and pesticide additives. The Company distributes its products primarily in domestic market.

Number of employees: 658

Managers	Title	Age	Since
Ren Rong Wu CEO	Chief Executive Officer	61	01/00/01
Qun Song Tang DFI	Director of Finance/CFO	56	01/00/01
Rong Wen Wu CHM	Chairman	58	01/00/01
Zheng Song Gao CTO	Chief Tech/Sci/R&D Officer	58	01/00/01
Jiu Si Shen BRD	Director/Board Member	54	18/23/18
You Hong Li BRD	Director/Board Member	60	01/07/01
Xin Guo Chen BRD	Director/Board Member	55	01/00/01
Jian Zhang IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
Ya Mei Guan BRD	Director/Board Member	54	18/23/18
Ren Rong Wu CEO	Chief Executive Officer	61	01/00/01
Zheng Song Gao CTO	Chief Tech/Sci/R&D Officer	58	01/00/01
Xin Guo Chen BRD	Director/Board Member	55	01/00/01
Rong Wen Wu CHM	Chairman	58	01/00/01
You Hong Li BRD	Director/Board Member	60	01/07/01
Jiu Si Shen BRD	Director/Board Member	54	18/23/18
Hui Peng BRD	Director/Board Member	56	12/22/12
Ming Wei BRD	Director/Board Member	36	18/23/18
Guo Feng Guan BRD	Director/Board Member	62	18/23/18

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	138,326,152	50,266,043 ( 36.34 %)	2,887,020 ( 2.087 %)	36.34 %

Name	Equities	%	Valuation
Zhong Geng Fund Management Co. , Ltd. 3.396 %	4,437,400	3.396 %	14 M ¥
Everbright PGIM Fund Management Co. Ltd. 0.2728 %	356,500	0.2728 %	1 M ¥
Truvalue Asset Management Co. Ltd. 0.1913 %	250,000	0.1913 %	777 938 ¥
Morgan Stanley Huaxin Fund Management Co., Ltd. 0.0871 %	113,800	0.0871 %	354 117 ¥
Gfund Management Co., Ltd. 0.0585 %	76,400	0.0585 %	237 738 ¥
Guotai Asset Management Co., Ltd. 0.0423 %	55,300	0.0423 %	172 080 ¥
ABC-CA Fund Management Co., Ltd. 0.004592 %	6,000	0.004592 %	18 671 ¥
Fullgoal Fund Management Co., Ltd. 0.003291 %	4,300	0.003291 %	13 381 ¥
Zhong Ou Asset Management Co., Ltd 0.000765 %	1,000	0.000765 %	3 112 ¥

Nanjing Well Pharmaceutical Co., Ltd.

Building 5, Rsch & Dev Area 5 Xuzhuang Software Park

210042, Nanjing

http://www.well-js.com

address Nanjing Well Pharmaceutical Group Co.,Ltd.(603351)

Energy - Fossil Fuels

Oil & Gas Refining and Marketing

Other Oil & Gas Refining and Marketing

	1st Jan change	Capi.
NANJING WELL PHARMACEUTICAL GROUP CO.,LTD.	-6.41%	462M
RELIANCE INDUSTRIES LTD	+10.95%	233B
CHINA PETROLEUM & CHEMICAL CORPORATION	+14.43%	100B
MARATHON PETROLEUM CORPORATION	+23.05%	64.32B
PHILLIPS 66	+7.86%	60.88B
VALERO ENERGY CORPORATION	+20.65%	51.29B
IMPERIAL OIL LIMITED	+23.36%	36.46B
INDIAN OIL CORPORATION LIMITED	+31.50%	28.2B
FORMOSA PETROCHEMICAL CORPORATION	-11.15%	21.15B
REPSOL S.A.	+6.88%	18.84B

Other Oil & Gas Refining and Marketing